Results 251 to 259 of about 4,942 (259)

Prognoseverbesserung durch Lipidsenker Inclisiran: "Erste Einblicke"

CardioVasc, 2023
openaire   +1 more source

Inclisiran/pantoprazole

Reactions Weekly
openaire   +1 more source

The Impact of Inclisiran on Lipid Profiles in Adults with Hyperlipidemia: A Meta-Analysis and Meta Regression of Randomized Controlled Trials.

American Journal of Cardiology
I. Khalil, Mohd Turzo Rahman, Imran Hossain   +2 more
semanticscholar   +1 more source

Comparative metabolism of an N-acetylgalactosamine-conjugated small interfering RNA, inclisiran, among various in vitro systems and correlations with in vivo metabolism in rats.

Drug Metabolism And Disposition
Hong Zhang, Gengyao Qin, Liqi Shi, Ruixing Li, Liang Shen, Weiqun Cao, Yi Tao   +6 more
semanticscholar   +1 more source

LDL-C management with inclisiran plus usual care vs usual care alone in participants with recent acute coronary syndrome: VICTORION-INCEPTION

Journal of Clinical Lipidology
A. Navar, Jeffrey L. Anderson, Alan S. Brown, J. Muhlestein, K. Kleeman, S. Sarwat, C. Abbas, M. Ramirez, Cindy L. Grines, Wael Abo-Auda, Nihar R. Desai, Kirk Knowlton   +11 more
semanticscholar   +1 more source

Evolocumab/Inclisiran/Tirzepatide

Reactions Weekly
openaire   +1 more source

Cost-Effectiveness Analysis of Inclisiran for the Treatment of Primary Hypercholesterolemia or Mixed Dyslipidemia in Singapore.

Value in Health Regional Issues
Yan Ling Lim, Ru San Tan, K. Poh, Xiao Jun Wang   +3 more
semanticscholar   +1 more source

Lipid lowering therapies: Demystifying inclisiran▼

Pharmaceutical Journal
openaire   +1 more source

Inclisiran - Starke und dauerhafte LDL-Senkung

Österreichische Apothekerzeitung, 2020
openaire   +1 more source